Compare HSAI & GRDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HSAI | GRDN |
|---|---|---|
| Founded | 2014 | 2004 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | | Retail-Drug Stores and Proprietary Stores |
| Sector | | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.7B |
| IPO Year | 2021 | 2023 |
| Metric | HSAI | GRDN |
|---|---|---|
| Price | $12.97 | $40.30 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 19 | 7 |
| Target Price | $28.03 | ★ $49.86 |
| AVG Volume (30 Days) | ★ 1.0M | 430.7K |
| Earning Date | 11-10-2026 | 11-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | ★ $1,448,685,000.00 |
| Revenue This Year | $41.54 | N/A |
| Revenue Next Year | $41.46 | $6.35 |
| P/E Ratio | ★ $61.18 | $117.77 |
| Revenue Growth | N/A | ★ 17.93 |
| 52 Week Low | $12.36 | $25.06 |
| 52 Week High | $29.35 | $48.33 |
| Indicator | HSAI | GRDN |
|---|---|---|
| Relative Strength Index (RSI) | 31.13 | 42.50 |
| Support Level | N/A | $38.49 |
| Resistance Level | $19.29 | $43.40 |
| Average True Range (ATR) | 0.49 | 1.22 |
| MACD | -0.30 | -0.27 |
| Stochastic Oscillator | 14.11 | 17.65 |
Hesai Group is engaged in the development, manufacture, and sales of three-dimensional light detection and ranging solutions, or LiDAR. Its LiDAR products enable a broad spectrum of applications across passenger or commercial vehicles with enhanced driver assistance systems, or ADAS, autonomous vehicle fleets providing passenger and freight mobility services, or Autonomous Mobility, and other applications such as last-mile delivery robots, street sweeping robots, and logistics robots in restricted areas, or Robotics. Geographically, the company operates in North America, Mainland China, Europe, and Other regions.
Guardian Pharmacy Services Inc is a pharmacy services company providing technology-enabled services to help residents of long-term health care facilities (LTCFs) adhere to appropriate drug regimens, reducing the cost of care and improving clinical outcomes. The Company provides high-touch clinical, drug dispensing, and administration services tailored to residents in assisted living facilities, behavioral health facilities, and group homes, while also serving residents in all types of LTCFs. It partners with residents, LTCFs, and health plan payors to help reduce errors in drug administration, manage drug regimens, and improve adherence. The Company derives its revenue mainly from the sale of pharmaceutical and medical products.